---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-067952"
form_type: "8-K"
ticker: "RLAY"
cik: "0001812364"
company_name: "Relay Therapeutics, Inc."
filed_at: "2024-06-03T23:59:59+00:00"
generated_at: "2026-06-01T06:53:24.982894+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Relay Therapeutics annual meeting; executive compensation advisory vote passes with 60% support

## Summary
- Stockholders elected Sanjiv K. Patel (109.9M for) and Linda A. Hill (91.3M for) as class I directors.
- Non-binding advisory vote on executive compensation passed: 66.7M for, 44.7M against (40% opposed).
- Ratification of Ernst & Young as auditor for FY2024 approved with 119.4 million votes for.
- Broker non-votes totaled 8.2M on director election and advisory compensation proposals.

## SEC filing metadata
- accession: 0000950170-24-067952
- form_type: 8-K
- ticker: RLAY
- cik: 0001812364
- company_name: Relay Therapeutics, Inc.
- filed_at: 2024-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/0000950170-24-067952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812364/000095017024067952/rlay-20240603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-067952
- JSON: https://secwatch.observer/filing/0000950170-24-067952.json
- Plain text: https://secwatch.observer/filing/0000950170-24-067952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.